Render Target: STATIC
Render Timestamp:
3/28/2025, 6:31:15 AM EDT
3/28/2025, 10:31:15 AM UTC
Commit: 461ca8d8fe5b1efd4c01fc87e5b5eb592e2d154a
Cell Signaling Technology Logo
1% for the planet logo

NF-κB Signaling

Access the full library of downloadable pathway diagrams, along with recommended products for each signaling pathway.

TRADD TRAF6 TRAF6 Pellino β-TrCP TAK1 JNK TAB1/2 A20 RNF11 IL-1R IL-1R IKKβ IKKγ/ NEMO IKKα RIP Tax c-IAP1/2 β-TrCP GF-Rs LTβR, BR3 CD40 GF-Rs TRAF2/5 TNFR TNFR Ras Cot Akt PI3K PDK1 TRAF3 NIK TRAF2 TRAF2/6 SHARPIN IKKα IKKα RelB NF-κB2 p100 IKKα IKKα RelB NF-κB2 p52 RelB NF-κB2 p52 H3 PARP1 IKKα IKKα NAP1 PCAF IKKγ/ NEMO ATM IKKγ/ NEMO NAK HDAC PIASg CBP/ p300 RSK1 PKA C CK2 NF-κB p50/52 p65/ RelA NF-κB p50/52 p65/ RelA GSK-3β MSK1 IKKα/β/θ PKCζ RelA/cRel NF-kB1 p50 IκBα/β/θ IκBα NF-κB2 p52 p65/ RelA p38 CK2 NF-κB1 p50 RelA/cRel IκBα/θ NF-κB p50/52 NF-κB p50/52 Bcl-3 CYLD ITCH ELKS ubc13 IκBζ Ubc13 HOIP HOIL1 UEV1A IRAK1/4 Proteasomal Degradation Survival, Proliferation, Inflammation, Immune Regulation Lymphogenesis, B Cell Maturation Proteasomal Processing Genotoxic Stress Stress: ROIs, UV, Metals, Ischemia, Shear IL-1 LT, CD40L, BAFF/BLys Growth Factors: BMP, EGF, HGH, Insulin, NGF, TGF-a TNF UV For detailed signaling, see BCR Pathway. Ag-MHC LPS, CpG, ssRNA, dsRNA For detailed signaling, see TLR Pathway. For detailed signaling, see TCR Pathway. CYLD Nucleus Cytoplasm c-IAP1/2 TAX1BP1 MyD88 Ag LUBAC TLRs TLRs K48-Ubiquitin Acetylation Sumoylation K63-Ubiquitin TCR TCR Nuclear-Cytoplasmic Shuttling of Non- Phosphorylated Forms BCR BCR rev. 02/27/20 NF-κB Signaling

2025 © Cell Signaling Technology. All Rights Reserved.

Nuclear factor-κB (NF-κB)/Rel proteins include NF-κB2 p52/p100, NF-κB1 p50/p105, c-Rel, RelA/p65, and RelB. These proteins function as dimeric transcription factors that regulate the expression of genes influencing a broad range of biological processes including innate and adaptive immunity, inflammation, stress responses, B-cell development, and lymphoid organogenesis. In the classical (or canonical) pathway, NF-κB/Rel proteins are bound and inhibited by IκB proteins. Proinflammatory cytokines, LPS, growth factors, and antigen receptors activate an IKK complex (IKKβ, IKKα, and NEMO), which phosphorylates IκB proteins. Phosphorylation of IκB leads to its ubiquitination and proteasomal degradation, freeing NF-κB/Rel complexes. Active NF-κB/Rel complexes are further activated by post-translational modifications (phosphorylation, acetylation, glycosylation) and translocate to the nucleus where, either alone or in combination with other transcription factors including AP-1, Ets, and Stat, they induce target gene expression. In the alternative (or noncanonical) NF-κB pathway, NF-κB2 p100/RelB complexes are inactive in the cytoplasm. Signaling through a subset of receptors, including LTβR, CD40, and BR3, activates the kinase NIK, which in turn activates IKKα complexes that phosphorylate C-terminal residues in NF-κB2 p100. Phosphorylation of NF-κB2 p100 leads to its ubiquitination and proteasomal processing to NF-κB2 p52. This creates transcriptionally competent NF-κB p52/RelB complexes that translocate to the nucleus and induce target gene expression. Only a subset of NF-κB agonists and target genes are shown here.

Selected Reviews:

We would like to thank Prof. Thomas D. Gilmore, Boston University, Boston, MA, for contributing to this diagram.

created July 2009

revised May 2014